Thyroid autoantibodies

Endocrinology and Metabolism Clinics of North America

Volumn 30, Issue 2, 2001, Pages 315-337

  Saravanan, P ^a   Dayan, C M ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ANTIGEN; SODIUM IODIDE; THIONAMIDE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; AUTOMATION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; FOLLOW UP; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; IMMUNOASSAY; IMMUNOBIOLOGY; INTERMETHOD COMPARISON; METHODOLOGY; PREGNANCY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REMISSION; REVIEW; TECHNIQUE; THYROID CANCER;

EID: 0034953212     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70189-4     Document Type: Article

References (150)

1. Abnormal responses in the assay of thyrotropin
2. Development of thyroid autoimmunity
3. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease
4. Molecular studies on thyrotropin (TSH) receptor and anti-TSH receptor antibodies
5. Pathogenesis of Graves' disease: Molecular analysis of anti-thyrotropin receptor antibodies
6. Long-term prospective study of postpartum thyroid dysfunction in women with insulin-dependent diabetes mellitus
7. Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: Its usefulness in the diagnosis of autoimmune thyroid diseases
8. Understanding the immunology of Graves' ophthalmopathy: Is it an autoimmune disease?
9. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin
10. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy
11. Fluorescent antibody studies in human thyroiditis: Auto-antibodies to an antigen of the thyroid colloid distinct from thyroglobulin
12. Thyroid autoantibodies in an Australian community
13. Thyroid function and autoimmune manifestations in insulin-dependent diabetes mellitus during and after pregnancy
14. Autoantibodies reactive with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy
15. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase
16. Response to methimazole in Graves' disease: The European Multicenter Study Group
17. Prevalence of thyroid dysfunction in elderly subjects: A randomized study in a Norwegian rural community (Naeroy)
18. Thyroid antibodies in northern Norway: Prevalence, persistence and relevance
19. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management
20. Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions
21. Na+/I- symporter distribution in human thyroid tissues: An immunohistochemical study
22. A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies
23. Outcome of thyroid function in Graves' patients treated with radioiodine: Role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage
24. High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with nongoitrous autoimmune thyroiditis
25. Specific and nonspecific response in the bioassay of the long-acting thyroid stimulator (LATS)
26. Controversies in reproductive immunology
27. Second-generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease
28. Cloning and characterization of the thyroid iodide transporter
29. Thyroid controversy - Stimulating antibodies
30. Value of thyroid-stimulating antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease
31. The natural history of autoimmune thyroiditis: How normal is autoimmunity?
32. Interpretation of thyroid function tests
33. Chronic autoimmune thyroiditis
34. Autoantibodies to thyroxin and triiodothyronine
35. Thyroid growth stimulating and blocking immunoglobulins
36. The involvement of the pentose shunt in thyroid metabolism after stimulation with TSH or with immunoglobulins from patients with thyroid disease: 1. The generation of NADPH in relation to stimulation of thyroid growth
37. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease
38. Development of a luminescent bioassay for thyroid stimulating antibodies
39. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor
40. AACE clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism
41. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
42. How common is postpartum thyroiditis?: A methodologic overview of the literature
43. Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus
44. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: Associations with serum lipids
45. The presence of antithyroid antibodies in euthyroid patients with unexplained infertility and tubal obstruction
46. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease
47. Predictors of early remission of hyperthyroidism in children
48. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors
49. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism
50. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: Autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism
51. A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin
52. Role of the eye muscles in thyroid eye disease: Identification of the principal autoantigens
53. Postpartum depression and thyroid antibody status
54. Transient post-partum thyroid dysfunction and postnatal depression
55. Association between postpartum thyroid dysfunction and thyroid antibodies and depression
56. Zur kenntniss der lymphomatosen veranderung der schilddruse (Struma lymphomatosa)
57. Diagnostic significance of thyroid microsomal antibodies in randomly selected population
58. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy
59. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative western blot
60. Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy
61. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease
62. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies
63. Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis
64. Thyroid-stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: Indicators of activity of disease
65. A study of untreated Graves' patients with undetectable TSH-binding inhibitor immunoglobulins and the effect of antithyroid drugs
66. Value of thyroid-stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients
67. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy
68. Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: Therapeutic implications
69. Human thyroid peroxidase: Complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs
70. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: Evidence for the "forbidden clone" theory
71. Thyroid stimulating blocking antibodies - An overview
72. The IgG subclass distribution of TSH receptor blocking antibodies in primary hypothyroidism
73. Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema
74. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: The corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism
75. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction
76. Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer
77. Guidelines for TSH-receptor antibody measurements in pregnancy: Results of an evidence-based symposium organized by the European Thyroid Association
78. Clinical mamfestations of postpartum thyroid disease
79. The prevalence and progression of autoimmune thyroid disease in the elderly
80. The clinical spectrum of postpartum thyroid disease
81. Subclinical autoimmunity in recurrent aborters
82. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA
83. Thyroid autoimmunity and aging
84. Thyroid and other organ-specific autoantibodies in healthy centenarians
85. TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring
86. Molecular analysis of the antibody response to thyroglobulin and thyroid peroxidase
87. Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: Markers of the human thyroid autoimmune response
88. In vitro generation of NADPH as an index of thyroid stimulating immunoglobulins (TGI) in goitrous disease
89. Thyroid growth immunoglobulins in large multinodular endemic goiters: Effect of iodized oil
90. The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs
91. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity
92. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period
93. The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thryoiditis
94. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome
95. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis
96. Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis
97. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema
98. Anti-TSH receptor antibodies in clinical practice
99. A long-term follow-up of postpartum thyroiditis
100. Molecular cloning of the thyrotropin receptor
101. Fetal cord blood sampling in the diagnosis and the treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother, producing thyroid-stimulating immunoglobulins
102. Postpartum thyroid dysfunction and depression in an unselected population
103. Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression
104. Maternal thyroid peroxidase antibodies during pregnancy: A marker of impaired child development?
105. Are autoimmune thyroid dysfunction and depression related?
106. Molecular cloning and characterization of human thyroid peroxidase antibodies of lambda light chain type
107. Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss
108. Postpartum thyroiditis and long-term thyroid status: Prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity
109. Isolation and characterization of a monoclonal human thyroid peroxidase autoantibody of lambda light chain type
110. Identification of the thyroid Na +/I- cotransporter as a potential autoantigen in thyroid autoimmune disease
111. Differentiation of Hashimoto's thyroiditis from thyroid neoplasms in fine-needle aspirates
112. Autoantibodies to the thyrotropin receptor
113. The different types of hyperthyroidism in Europe: Results of a prospective survey of 924 patients
114. An unusual instance of thyroxine binding by human serum gamma globulin
115. Autoantibodies in Hashimoto's disease (lymphadenoid goitre)
116. The cytoplasmic auto-antigen of human thyroid: Immunological and biochemical considerations
117. Bispecific thyroglobulin and thyroid peroxidase autoantibodies in patients with various thyroid and autoimmune diseases
118. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy
119. Implications of the molecular characterization of the sodium-iodide symporter (NIS)
120. Selective binding of thyrotropin receptor autoantibodies to recombinant extracellular domain of thyrotropin/lutropin-chorionic gonadotropin receptor chimeric proteins
121. The relationship of thyrotropin receptor antibody levels to the severity of thyroid orbitopathy
122. Treatment guidelines for patients with hyper-thyroidism and hypothyroidism: Standards of Care Committee, American Thyroid Association
123. Presence of thyroid antibodies in early reproductive failure: Biochemical versus clinical pregnancies
124. Usefulness of antimicrosomal antibody titers in the diagnosis and treatment of postpartum thyroiditis
125. Recoveries cannot be used to authenticate thyroglobulin (Tg) measurements when sera contain Tg autoantibodies
126. The immune response to the iodide transporter
127. Recognizing, understanding, and treating postpartum thyroiditis
128. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies
129. Long-term follow-up and HLA association in patients with postpartum hypothyroidism
130. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects
131. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis
132. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan
133. Graves' hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine - A prospective, randomized study
134. The spectrum of thyroid disease in a community: The Whickham survey
135. Antibodies to 'second colloid antigen': A study on the prevalence in sporadic forms of congenital hypothyroidism
136. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham survey
137. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment
138. A new chemiluminescent assay for the rapid detection of thyroid-stimulating antibodies in Graves' disease
139. New aspects of thyroid immunity
140. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy
141. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses
142. The post-mortem incidence of focal thyroiditis
143. Thyroid antibody titer and avidity in patients with recurrent miscarriage
144. Limited usefulness of antithyroperoxidase and antithyroglobulin assays in Jamaicans with Graves' disease
145. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases
146. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease
147. 131I treatment for Graves' disease
148. The thyroid-stimulating antibody of Graves' disease: Evidence for restricted heterogeneity
149. Restricted tissue reactivity of autoantibodies to a 64-kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy
150. Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy